Article
Advances in Breast Cancer From AACR 2023
Therapies combining PARP plus PD-L1 inhibition, PARP inhibition plus chemotherapy, and whole tumor cell therapeutic vaccines are among breast...
Article
Key Takeaways in Early Breast Cancer From AACR 2023
A novel agent used to visualize positive margins in lumpectomy, the effect of race on skin toxicity in radiotherapy, and DCIS recurrence are key...
